These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15799382)

  • 21. [Early diagnosis of kidney disorders induced by nephrotoxic substances].
    Gejo F; Arakawa M
    Nihon Naika Gakkai Zasshi; 1994 Oct; 83(10):1720-3. PubMed ID: 7814942
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reticuloendotherial system involvement in rheumatoid arthritis].
    Takasaki Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():270-3. PubMed ID: 15799359
    [No Abstract]   [Full Text] [Related]  

  • 23. Rheumatoid arthritis and the kidney.
    Pathan E; Joshi VR
    J Assoc Physicians India; 2004 Jun; 52():488-94. PubMed ID: 15645961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methodology for assessment of renal function].
    Hayashi K; Wakino S; Tokuyama H
    Nihon Rinsho; 2008 Sep; 66(9):1719-22. PubMed ID: 18788400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
    Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta-N-acetylglucosaminidase (beta-NAG) as a parameter in the diagnosis and evaluation of primary glomerular and tubulointerstitial kidney diseases].
    Hauser AC; Fabrizii V; Derfler K; Balcke P
    Wien Klin Wochenschr Suppl; 1991; 189():13-6. PubMed ID: 1962476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Routine kidney function tests for the diagnosis of kidney diseases].
    Orita Y
    Nihon Naika Gakkai Zasshi; 1990 Feb; 79(2):140-5. PubMed ID: 2193990
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal manifestations of rheumatological disorders.
    Biswas S; Paul R
    J Indian Med Assoc; 2013 Aug; 111(8):542-4, 552. PubMed ID: 24783393
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of cystatin C. Not a reliable way to estimate renal function--and rather expensive!].
    Saeed A; Svensson MK; Herlitz H; Samuelsson O
    Lakartidningen; 2008 May 21-27; 105(21):1588-9. PubMed ID: 18574997
    [No Abstract]   [Full Text] [Related]  

  • 31. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.
    Uda H; Yokota A; Kobayashi K; Miyake T; Fushimi H; Maeda A; Saiki O
    J Rheumatol; 2006 Aug; 33(8):1482-7. PubMed ID: 16881107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process.
    Kristensen K; Lindström V; Schmidt C; Blirup-Jensen S; Grubb A; Wide-Swensson D; Strevens H
    Scand J Clin Lab Invest; 2007; 67(6):612-8. PubMed ID: 17852800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New data on the intraindividual variation of cystatin C.
    Delanaye P; Cavalier E; Depas G; Chapelle JP; Krzesinski JM
    Nephron Clin Pract; 2008; 108(4):c246-8. PubMed ID: 18391572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of beta-2-microglobulin concentration in serum and urine in rheumatoid arthritis.
    Lewandowski B; Bernacka K; Kucharewicz B; Szmitkowski M; Klimiuk PA
    Rocz Akad Med Bialymst; 1996; 41(2):482-91. PubMed ID: 9020562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic kidney disease in the elderly--how to assess risk.
    Stevens LA; Levey AS
    N Engl J Med; 2005 May; 352(20):2122-4. PubMed ID: 15901867
    [No Abstract]   [Full Text] [Related]  

  • 36. Measuring renal function with urea and creatinine tests.
    Higgins C
    Nurs Times; 1994 Dec 21-1995 Jan 3; 90(51):34-6. PubMed ID: 7816667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystatin C and the risk of death.
    Perkins BA; Nelson RG; Krolewski AS
    N Engl J Med; 2005 Aug; 353(8):842-4; author reply 842-4. PubMed ID: 16124125
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical evaluation of kidney function.
    Remmers AR
    Tex Med; 1973 Jul; 69(7):48-50. PubMed ID: 4720633
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.
    Dharnidharka VR; Kwon C; Stevens G
    Am J Kidney Dis; 2002 Aug; 40(2):221-6. PubMed ID: 12148093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum cystatin C: a replacement for creatinine as a biochemical marker of GFR.
    Newman DJ; Thakkar H; Edwards RG; Wilkie M; White T; Grubb AO; Price CP
    Kidney Int Suppl; 1994 Nov; 47():S20-1. PubMed ID: 7869665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.